Neoadjuvant therapy (NAT) for early breast cancer was first introduced in the 1980s to downstage large, inoperable tumors, ...
Esophageal cancer poses a major health concern in the US, representing 1% of all cancer diagnoses and 2.6% of cancer-related ...
A nationwide DMP for HTN in Austria leveraging telemedical tools is both feasible and urgently needed. Key success factors include clear inclusion criteria, technology access, comprehensive training, ...
Oral therapy options in oncology are increasingly valued for their convenience, reduced need for intravenous access, and lower “time toxicity.” These factors are among the main arguments in favor of ...
Effective immunomodulation of T-cell responses is critical in treating both autoimmune diseases and cancer. Our previous studies have demonstrated that secretomes derived from control or ...
HLH is a rare disease with an estimated yearly incidence (equivalent to the prevalence) of 0.1/10,000 when accounting for both primary and secondary forms (Henter et al. 1991; Meeths et al. 2011). The ...
Perioperative anemia and blood transfusions are frequent and both are associated with a worse outcome in patients undergoing ...
Internationale evidenzbasierte Abklärungsalgorithmen bei Kleinwuchs betonen die Wichtigkeit von Körpermessdaten: Nicht ein ...
Positronen-Emissions-Tomographie- (PET-)Verfahren sind ein zentrales Instrument in der Diagnostik neurodegenerativer ...
Enterocutaneous fistulas (ECFs) are defined as abnormal connections between the gastrointestinal system (GIS) and the skin.
Zur Datenerhebung wurden leitfadengestützte, halbstrukturierte Interviews durchgeführt. Der Interviewleitfaden wurde entlang ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback